FDA & CDC Resume Use of the J&J COVID-19 Vaccine

As of April 25, 2021, the CDC and the U.S. Food and Drug Administration (FDA) recommend use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States.

Following the FDA and CDC’s decision, the Public Health Communications Collaborative updated their Tough Q&A with messaging to help you address questions from the community.